Voloridge Investment Management
GOSS icon

Voloridge Investment Management’s Gossamer Bio GOSS Stock Holding History

Voloridge Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,240
Closed -$4.06M – 1515
2022
Q3 		$4.06M Buy
+4,240
New +$4.21M 0.02% 722
2020
Q4 		– Sell
-150
Closed -$148K – 1413
2020
Q3 		$148K Buy
+150
New +$159K ﹤0.01% 1204
2020
Q2 		– Sell
-256
Closed -$208K – 1351
2020
Q1 		$208K Buy
+256
New +$267K 0.01% 941

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voloridge Investment Management's GOSS Position: Q4 2022 in Review

Voloridge Investment Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 4,240 shares — an estimated $4.06M sold.

Voloridge Investment Management first reported a position in GOSS in Q1 2020 and held it in 3 quarters. The position peaked at $4.06M in Q3 2022. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Voloridge Investment Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 4,240 Gossamer Bio shares in Q4 2022, an estimated $4.06M.
  • Voloridge Investment Management first reported a position in Gossamer Bio in Q1 2020 and held it in 3 quarters.
  • Voloridge Investment Management's Gossamer Bio position peaked at $4.06M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.